Structure-activity studies of endothelin leading to novel peptide ETA antagonists

https://doi.org/10.1016/S0968-0896(00)82103-3Get rights and content

Abstract

With the goal of producing receptor antagonists, numerous monocyclic and bicyclic endothelin analogs were prepared and tested for vasoconstrictor activity, receptor affinity and functional antagonist activity. Bis-penicillamine endothelin analogs containing Ala or Asn at position 18 were functional antagonists, with Ki values of 20–40 nM but KB values of about 1 μM (e.g., [Pen1,11, Nle7, Ala18]-endothelin-1, Ki = 42 nM, KB = 1.2 μM). While these peptides are antagonists at the ETA receptor, they appeal to be at least partial agonists at another receptor subtype.

Bis-penicillamine endothelin analogs containing Ala or Asn at position 18 were functional antagonists (e.g., [Pen1,11, Nle7, Ala18]-endothelin-1, Ki = 42 nM, KB = 1.2 μM).

  1. Download : Download full-size image

References (30)

  • T. Kosaka et al.

    FEBS Lett.

    (1989)
  • S. Moreland et al.

    Biochem. Biophys. Res. Commun.

    (1992)
  • M. Fujimoto et al.

    FEBS Letters

    (1992)
  • J.T. Hunt et al.

    Bio-Org. Med. Chem. Lett.

    (1991)
  • K. Nakajima et al.

    Biochem. Biophys. Res. Commun.

    (1989)
  • K. Nishikori et al.

    Neurochem. Int.

    (1991)
  • M.L. Webb et al.

    Biochem. Biophys. Res. Commun.

    (1992)
  • M. Yanagisawa et al.

    Nature

    (198)
  • A.M. Doherty

    J. Med. Chem.

    (1992)
  • Y. Kloog et al.

    Science

    (1988)
  • H. Arai et al.

    Nature

    (1990)
  • T. Sakurai et al.

    Nature

    (1990)
  • M. Ihara et al.

    Life Sci.

    (1992)
  • S. Nakajima et al.

    The Journal of Antibiotics

    (1991)
  • S. Miyata et al.

    The Journal of Antibiotics

    (1992)
  • Cited by (0)

    View full text